Organizational structure and funding of health technology assessment agencies around the world

Organizational structure and funding of health technology assessment agencies around the world

Aim: analyze the structure and funding of health technology assessment (HTA) agencies abroad.Materials and methods. Here, we review the organizational structure and funding of HTA agencies in Europe (Austria, Belgium, Germany, Ireland, the Netherlands, the United Kingdom, France, and Sweden), Canada...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2019-07-01
Series:	Фармакоэкономика
Subjects:	hta-agency international practice health technology assessment hta funding organizational structure
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/294
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ARM’s Perspective on the First Joint Clinical Assessments for ATMPs: Challenges and Opportunities on the Path Ahead
by: Paolo Morgese, et al.
Published: (2025-04-01)

What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
by: Oriol Solà-Morales, et al.
Published: (2025-01-01)

HTA CORE MODEL
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
by: Julia I. Drake, et al.
Published: (2017-01-01)

Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?
by: Sandro Gsteiger, et al.
Published: (2024-11-01)

The EU Health Technology Assessment Regulation Halo Effect: Are Cross-Functional Teams Ready?
by: Sian Tanner, et al.
Published: (2025-01-01)

Balanced assessment systems revisited
by: Dávid Dankó, et al.
Published: (2017-01-01)

EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?
by: Volker Schuster
Published: (2024-05-01)

A systematic literature review of real-world evidence (RWE) on post-market assessment of medical devices
by: Stefania Manetti, et al.

Do pregnant people have opportunities to participate in clinical trials? an exploratory survey of NIHR HTA-funded trialists
by: Rebekah Burrow, et al.
Published: (2025-07-01)

Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology
by: Caitlin Clunie-O’Connor, et al.
Published: (2025-07-01)

Health Technology Assessment in Taiwan: Reflections of the Last Twenty Years
by: Shih-Chung Chen
Published: (2023-12-01)

Access in all areas? A roundup of developments in market access and health technology assessment: part 6
by: Annie Jullien Pannelay, et al.
Published: (2025-01-01)

Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context
by: Agostino Fortunato, et al.
Published: (2025-07-01)

Clinical study and Health Technology Assessment (HTA) of a Robot-Assisted Gait Training on children with neurological disorders: A quasi-experimental study
by: Simone GAZZELLINI, et al.
Published: (2023-03-01)

Evaluation du système de surveillance de l’hypertension artérielle et du diabète dans le cadre de l’approche WHOPEN dans le District Sanitaire de Golfe, Togo, 2023
by: Bassotom Lakougnon, et al.
Published: (2025-06-01)

La COVID -19 en un paciente hipertenso
by: Jacno Erik Ferrer Castro, et al.
Published: (2020-09-01)

Complications of the COVID-19 in a hypertensive patient
by: Jacno Erik Ferrer Castro, et al.
Published: (2020-09-01)

Developing a Dynamic Simulation Model for Point-of-Care Ultrasound Assessment and Learning Curve Analysis
by: Sandra Usaquén-Perilla, et al.
Published: (2025-07-01)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
by: Santiago G. Moreno, et al.
Published: (2019-01-01)

Role of RWD / RWE in health technology assessment
by: V. G. Borovskaya, et al.
Published: (2023-03-01)

Situation analysis of evidence-informed health decision-making in Lao PDR: the case of health technology assessmentResearch in context
by: Sysavanh Phommachanh, et al.
Published: (2025-04-01)

Towards a Unified European View of Clinical Evidence: What ‘Health Technology Assessment Organizations’ Can Learn from Regulatory Experience
by: Karl Broich, et al.
Published: (2025-04-01)

The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01)

Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative
by: Zilke Claessens, et al.
Published: (2024-07-01)

Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs
by: Oriol Solà-Morales, et al.
Published: (2019-01-01)

Calidad del proceso en la ejecución del programa de Hipertensión Arterial
by: Naifi Hierrezuelo Rojas, et al.
Published: (2023-06-01)

Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands
by: Rimma Velikanova, et al.
Published: (2024-07-01)

The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy
by: Elaine Julian, et al.
Published: (2024-06-01)

Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment
by: Mondher Toumi, et al.
Published: (2017-01-01)

Enhancing Patient Engagement in HTA: Using Consensus Research to Overcome PICO Scoping Challenges Under the EU HTAR
by: Emanuele Arcà, et al.
Published: (2025-06-01)

Assessing the Value of Further Investment in R&D Using Mixed Methods: A Case Study of Biosensor-Integrated Arteriovenous Grafts
by: Samuel Owusu Achiaw, et al.
Published: (2025-01-01)

The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia
by: V. V. Omelyanovsky, et al.
Published: (2018-11-01)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19
by: Paul Arora, et al.
Published: (2025-05-01)

Translational research. Prospects in Russia
by: A. S. Kolbin, et al.
Published: (2018-02-01)

Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries
by: Jesper Jørgensen, et al.
Published: (2020-01-01)

Organizational mechanism for imlementation of the travel agency financial potential development strategy
by: І.V. Saukh
Published: (2017-03-01)

The effect of social network, funding and productive organizational energy on the capability of organizational ambidexterity in research institution
by: Novita Dyah, et al.
Published: (2016-06-01)

The effect of social network, funding and productive organizational energy on the capability of organizational ambidexterity in research institution
by: Novita Dyah, et al.
Published: (2016-06-01)

Reassembling Agency
by: Francis Lee
Published: (2025-06-01)